Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Crinetics Pharmaceuticals, Inc. (CRNX) had Free Cash Flow per Share of $-0.96 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.36M |
|
$-96.77M |
|
-- |
|
$0.36M |
|
$111.77M |
|
$-111.41M |
|
$14.63M |
|
$-96.77M |
|
$-96.77M |
|
$-96.77M |
|
$-96.77M |
|
$-96.77M |
|
$-96.77M |
|
$-111.41M |
|
$-114.86M |
|
93.10M |
|
93.10M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$1.29B |
|
$12.63M |
|
$70.27M |
|
$1.36B |
|
$57.31M |
|
-- |
|
$50.02M |
|
$107.33M |
|
$1.25B |
|
$1.25B |
|
$1.25B |
|
93.53M |
|
| Cash Flow Statement Financials | |
$-88.45M |
|
$-85.96M |
|
$4.44M |
|
$265.85M |
|
$95.87M |
|
$-169.98M |
|
$20.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-30860.11% |
|
-30860.11% |
|
-- |
|
-26807.20% |
|
-26807.20% |
|
$-89.69M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-7.72% |
|
-7.72% |
|
-7.11% |
|
-7.72% |
|
$13.41 |
|
|
Free Cash Flow per Share |
$-0.96 |
$-0.95 |
|